Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized crossover trial of teriparatide versus alfacalcidol + hydrochlorothiazide in autosomal dominant hypocalcemia
2016-000500-29Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of teriparatide and hydrochlorothiazide in autosomal dominant hypocalcemia (ADH) and hypoparathyroidism (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2016; status: completed.
02
Drugs
teriparatidehydrochlorothiazide
03
Conditions
autosomal dominant hypocalcemia (ADH)hypoparathyroidism
Beyond the preview
Go deeper on 2016-000500-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000500-29.